Literature DB >> 25301985

Intratumoral Iron Oxide Nanoparticle Hyperthermia and Radiation Cancer Treatment.

Pj Hoopes1, Rr Strawbridge1, Uj Gibson1, Q Zeng1, Ze Pierce1, M Savellano1, Ja Tate1, Ja Ogden1, I Baker1, R Ivkov2, Ar Foreman2.   

Abstract

The potential synergism and benefit of combined hyperthermia and radiation for cancer treatment is well established, but has yet to be optimized clinically. Specifically, the delivery of heat via external arrays /applicators or interstitial antennas has not demonstrated the spatial precision or specificity necessary to achieve appropriate a highly positive therapeutic ratio. Recently, antibody directed and possibly even non-antibody directed iron oxide nanoparticle hyperthermia has shown significant promise as a tumor treatment modality. Our studies are designed to determine the effects (safety and efficacy) of iron oxide nanoparticle hyperthermia and external beam radiation in a murine breast cancer model.
METHODS: MTG-B murine breast cancer cells (1 × 106) were implanted subcutaneous in 7 week-old female C3H/HeJ mice and grown to a treatment size of 150 mm3 +/- 50 mm3. Tumors were then injected locally with iron oxide nanoparticles and heated via an alternating magnetic field (AMF) generator operated at approximately 160 kHz and 400 - 550 Oe. Tumor growth was monitored daily using standard 3-D caliper measurement technique and formula. specific Mouse tumors were heated using a cooled, 36 mm diameter square copper tube induction coil which provided optimal heating in a 1 cm wide region in the center of the coil. Double dextran coated 80 nm iron oxide nanoparticles (Triton Biosystems) were used in all studies. Intra-tumor, peri-tumor and rectal (core body) temperatures were continually measured throughout the treatment period.
RESULTS: Preliminary in vivo nanoparticle-AMF hyperthermia (167 KHz and 400 or 550 Oe) studies demonstrated dose responsive cytotoxicity which enhanced the effects of external beam radiation. AMF associated eddy currents resulted in nonspecific temperature increases in exposed tissues which did not contain nanoparticles, however these effects were minor and not injurious to the mice. These studies also suggest that iron oxide nanoparticle hyperthermia is more effective than nonnanoparticle tumor heating techniques when similar thermal doses are applied. Initial electron and light microscopy studies of iron oxide nanoparticle and AMF exposed tumor cells show a rapid uptake of particles and acute cytotoxicity following AMF exposure.

Entities:  

Year:  2007        PMID: 25301985      PMCID: PMC4187389          DOI: 10.1117/12.706302

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  16 in total

1.  Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group.

Authors:  C C Vernon; J W Hand; S B Field; D Machin; J B Whaley; J van der Zee; W L van Putten; G C van Rhoon; J D van Dijk; D González González; F F Liu; P Goodman; M Sherar
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-07-01       Impact factor: 7.038

2.  Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer.

Authors:  Manfred Johannsen; Burghard Thiesen; Uwe Gneveckow; Kasra Taymoorian; Norbert Waldöfner; Regina Scholz; Serdar Deger; Klaus Jung; Stefan A Loening; Andreas Jordan
Journal:  Prostate       Date:  2006-01-01       Impact factor: 4.104

3.  Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy.

Authors:  Sally J DeNardo; Gerald L DeNardo; Laird A Miers; Arutselvan Natarajan; Alan R Foreman; Cordula Gruettner; Grete N Adamson; Robert Ivkov
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

4.  Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia.

Authors:  A Jordan; P Wust; H Fähling; W John; A Hinz; R Felix
Journal:  Int J Hyperthermia       Date:  1993 Jan-Feb       Impact factor: 3.914

5.  Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

Authors:  P K Sneed; P R Stauffer; M W McDermott; C J Diederich; K R Lamborn; M D Prados; S Chang; K A Weaver; L Spry; M K Malec; S A Lamb; B Voss; R L Davis; W M Wara; D A Larson; T L Phillips; P H Gutin
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-15       Impact factor: 7.038

6.  Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro.

Authors:  A Jordan; P Wust; R Scholz; B Tesche; H Fähling; T Mitrovics; T Vogl; J Cervós-Navarro; R Felix
Journal:  Int J Hyperthermia       Date:  1996 Nov-Dec       Impact factor: 3.914

7.  Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients.

Authors:  R Valdagni; M Amichetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-01-01       Impact factor: 7.038

8.  Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results.

Authors:  M Van Vulpen; A A C De Leeuw; B W Raaymakers; R J A Van Moorselaar; P Hofman; J J W Lagendijk; J J Battermann
Journal:  BJU Int       Date:  2004-01       Impact factor: 5.588

Review 9.  The cellular and molecular basis of hyperthermia.

Authors:  Bert Hildebrandt; Peter Wust; Olaf Ahlers; Annette Dieing; Geetha Sreenivasa; Thoralf Kerner; Roland Felix; Hanno Riess
Journal:  Crit Rev Oncol Hematol       Date:  2002-07       Impact factor: 6.312

10.  Efficacy of irradiation and external hyperthermia in locally advanced, hormone-refractory or radiation recurrent prostate cancer: a preliminary report.

Authors:  John A Kalapurakal; Margaret Pierce; Alan Chen; Vythialingam Sathiaseelan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-01       Impact factor: 7.038

View more
  6 in total

1.  The impact of data selection and fitting on SAR estimation for magnetic nanoparticle heating.

Authors:  Hattie L Ring; Anirudh Sharma; Robert Ivkov; John C Bischof
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

2.  Imaging the distribution of iron oxide nanoparticles in hypothermic perfused tissues.

Authors:  Hattie L Ring; Zhe Gao; Anirudh Sharma; Zonghu Han; Charles Lee; Kelvin G M Brockbank; Elizabeth D Greene; Kristi L Helke; Zhen Chen; Lia H Campbell; Bradley Weegman; Monica Davis; Michael Taylor; Sebastian Giwa; Gregory M Fahy; Brian Wowk; Roberto Pagotan; John C Bischof; Michael Garwood
Journal:  Magn Reson Med       Date:  2019-12-09       Impact factor: 4.668

3.  The Dartmouth Center for Cancer Nanotechnology Excellence: magnetic hyperthermia.

Authors:  Ian Baker; Steve N Fiering; Karl E Griswold; P Jack Hoopes; Katerina Kekalo; Christian Ndong; Keith Paulsen; Alicea A Petryk; Brian Pogue; Fridon Shubitidze; John Weaver
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

4.  Comparison of Iron Oxide Nanoparticle and Waterbath Hyperthermia Cytotoxicity.

Authors:  Ja Ogden; Ja Tate; Rr Strawbridge; R Ivkov; Pj Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-12

5.  Gold-coated iron oxide nanoparticles trigger apoptosis in the process of thermo-radiotherapy of U87-MG human glioma cells.

Authors:  Ali Neshastehriz; Zohreh Khosravi; Habib Ghaznavi; Ali Shakeri-Zadeh
Journal:  Radiat Environ Biophys       Date:  2018-09-10       Impact factor: 1.925

6.  Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia.

Authors:  C L Dennis; A J Jackson; J A Borchers; P J Hoopes; R Strawbridge; A R Foreman; J van Lierop; C Grüttner; R Ivkov
Journal:  Nanotechnology       Date:  2009-09-03       Impact factor: 3.874

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.